Kewaunee Scientific Corporation (KEQU) has received a recommendation upgrade to “Outperform,” based on strong acquisition execution, sustained margin improvement, a record backlog that underpins revenue visibility and partial insulation from macroeconomic headwinds via healthcare exposure.Acquisition Execution & Strategic FitThe November 2024 acquisition of Nu Aire, Inc. has already proven transformative, delivering a 30.7% year-over-year increase in domestic segment sales to $179.4 million in fiscal 2025.T ...